Despite Downturn, Investment Firm Survey Sees Emerging Uses for Microarrays | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Despite recent concerns about declining interest in and uses for microarray technology, the results of a survey conducted by investment firm William Blair suggest the technology still has a place in the research world, though likely in certain emerging applications.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.

The San Diego Union-Tribune takes a look at the work to be done in personalized medicine.

An op-ed in the Wall Street Journal calls for the establishment of a patent court staffed by judges and experts with science backgrounds.

In PLOS this week: variants that affect COPD biomarkers, high genetic diversity of Cryptococcus gattii in Brazil, and more.